Correlation Between Vigil Neuroscience and Telix Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Vigil Neuroscience and Telix Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vigil Neuroscience and Telix Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vigil Neuroscience and Telix Pharmaceuticals Limited, you can compare the effects of market volatilities on Vigil Neuroscience and Telix Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vigil Neuroscience with a short position of Telix Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vigil Neuroscience and Telix Pharmaceuticals.

Diversification Opportunities for Vigil Neuroscience and Telix Pharmaceuticals

-0.27

Correlation Coefficient

Vigil Neuroscience  Telix Pharmaceuticals

Very good diversification

The 3 months correlation between Vigil and Telix is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Vigil Neuroscience and Telix Pharmaceuticals Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telix Pharmaceuticals and Vigil Neuroscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vigil Neuroscience are associated (or correlated) with Telix Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telix Pharmaceuticals has no effect on the direction of Vigil Neuroscience i.e., Vigil Neuroscience and Telix Pharmaceuticals go up and down completely randomly.

Pair Corralation between Vigil Neuroscience and Telix Pharmaceuticals

Given the investment horizon of 90 days Vigil Neuroscience is expected to under-perform the Telix Pharmaceuticals. In addition to that, Vigil Neuroscience is 2.05 times more volatile than Telix Pharmaceuticals Limited. It trades about -0.15 of its total potential returns per unit of risk. Telix Pharmaceuticals Limited is currently generating about 0.0 per unit of volatility. If you would invest  1,515  in Telix Pharmaceuticals Limited on October 6, 2024 and sell it today you would lose (22.00) from holding Telix Pharmaceuticals Limited or give up 1.45% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	54.84%
Values	Daily Returns

Vigil Neuroscience  vs.  Telix Pharmaceuticals Limited

Vigil Neuroscience

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Vigil Neuroscience has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain quite persistent which may send shares a bit higher in February 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Telix Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Telix Pharmaceuticals Limited has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong essential indicators, Telix Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Vigil Neuroscience and Telix Pharmaceuticals

The main advantage of trading using opposite Vigil Neuroscience and Telix Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vigil Neuroscience position performs unexpectedly, Telix Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telix Pharmaceuticals will offset losses from the drop in Telix Pharmaceuticals' long position.

The idea behind Vigil Neuroscience and Telix Pharmaceuticals Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.